Estimated reading time: 2 minutes
Hair miniaturization is a process in which hair follicles shrink over time and produce thinning hair. This process is typical of androgenetic alopecia, also known as male or female pattern hair loss, and is one of the most common causes of hair loss.
During miniaturization, the hair follicles go through a cycle that is characterized by a shortening of the anagen phase (growth phase) and a lengthening of the telogen phase (resting phase). As a result, the new hairs that grow after the old hairs fall out become increasingly finer, shorter and lighter in color. Over time, the follicles can shrink so much that they only produce very fine, barely visible hair or even stop producing new hair altogether.
The main cause of hair miniaturization is an increased sensitivity of the hair follicles to dihydrotestosterone (DHT), a derivative of the male hormone testosterone. This hormone binds to the receptors in the hair follicles, causing them to shrink. Although this process is more common in men, it also affects women, especially after hormonal changes such as the menopause.
Treating hair miniaturization can present challenges, as the process is often difficult to reverse. Common treatment approaches include the use of drug therapies such as minoxidil, which is applied topically to promote blood flow to the scalp and stimulate hair follicles, or finasteride, which inhibits the conversion of testosterone to DHT. In addition, newer therapies such as Platelet Rich Plasma (PRP) or even hair transplants may be considered, depending on the severity of the hair loss and the patient’s individual situation.
